Effectiveness of Bivalent Boosters against Severe Omicron Infection
- PMID: 36734847
- PMCID: PMC9933929
- DOI: 10.1056/NEJMc2215471
Effectiveness of Bivalent Boosters against Severe Omicron Infection
Comment in
-
Bivalent Boosters against Severe Omicron Infection.N Engl J Med. 2023 May 4;388(18):1726. doi: 10.1056/NEJMc2303753. N Engl J Med. 2023. PMID: 37133606 No abstract available.
-
Bivalent Boosters against Severe Omicron Infection. Reply.N Engl J Med. 2023 May 4;388(18):1726-1727. doi: 10.1056/NEJMc2303753. N Engl J Med. 2023. PMID: 37133607 No abstract available.
References
-
- Food and Drug Administration. Coronavirus (COVID-19) update: FDA authorizes Moderna, Pfizer-BioNTech bivalent COVID-19 vaccines for use as a booster dose. Press release, August 31, 2022. (https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19...).
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources